Skip to main content
ALGORAE PHARMACEUTICALS LIMITED logo

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,159 across all filing types
Latest filing 2022-11-09 Declaration of Voting R…
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
Results of Meeting 3 pages 352.8KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement titled 'Results of Annual General Meeting held on 10 November 2022' by Living Cell Technologies Limited. It references compliance with ASX Listing Rule 3.13.2 and section 251AA(2) of the Corporations Act, which relate to disclosure of voting results at shareholder meetings. The content includes detailed voting results for various resolutions proposed at the AGM, such as adoption of the remuneration report, re-election of directors, ratification of placement shares, amendments to the constitution, and appointment/removal of directors. There is no financial data or management discussion, only the official voting outcomes. The document is about the official results of shareholder votes at the AGM, fitting the category 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length (6945 characters) and content confirm it is not merely a brief notice but a full announcement of voting results. Therefore, the correct classification is DVA with high confidence.
2022-11-09 English
2022 AGM Update - Cancellation of Online Attendance Option 2 pages 178.3KB
AGM Information Classification · 95% confidence The document is an ASX announcement from Living Cell Technologies Limited regarding the cancellation of the online attendance option for the 2022 Annual General Meeting (AGM). It references the AGM date and location, and encourages shareholders to email questions if they cannot attend in person. The document is short (4403 characters) and is clearly an announcement about the AGM logistics rather than the AGM materials or minutes themselves. There is no financial data, no detailed report, and no voting results. This fits the category of AGM Information announcements related to the meeting itself, specifically about attendance options. Therefore, the appropriate classification is AGM Information (AGM-R).
2022-11-03 English
AGM Update- Addendum to Notice of Annual General Meeting 7 pages 421.5KB
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and includes detailed information about the meeting date, venue, shareholder information, and proxy voting instructions. It also contains an addendum with additional resolutions related to the election of new directors. The content focuses on the meeting logistics, resolutions to be voted on, and proxy forms rather than financial data or results. There is no indication that this is the actual Annual Report or financial statements, but rather a notice and explanatory notes for the AGM. Therefore, this document fits the category of AGM Information (AGM-R).
2022-11-03 English
2022 AGM Update - Withdrawal of Resolutions 2 pages 181.0KB
AGM Information Classification · 95% confidence The document is an ASX announcement from Living Cell Technologies Limited dated 1 November 2022. It discusses the withdrawal of certain resolutions related to the 2022 Annual General Meeting (AGM), specifically resolutions concerning the re-election and removal of directors and the appointment of new directors. The document references the Notice of 2022 AGM and mentions that an Addendum to the Notice and updated Proxy Form will be provided. The content focuses on changes to the AGM agenda and board composition, which is typical of announcements related to AGM information rather than the full AGM report or minutes. The document is about the AGM meeting agenda and resolutions, not the full annual report or financial statements. Therefore, the document fits best under the category AGM Information (AGM-R). The document length (6455 characters) and content confirm it is a detailed announcement about AGM resolutions, not a full report or proxy statement.
2022-10-31 English
Board Changes 2 pages 163.5KB
Board/Management Information Classification · 95% confidence The document is an announcement from Living Cell Technologies Limited dated 31 October 2022, detailing resignations and appointments of directors on the company's board. It specifically mentions the resignations of three directors and the appointment of two new directors, as well as the continuation of the interim CEO. The content focuses solely on changes in the company's board of directors and does not include financial data, audit information, or other report types. The document is titled 'ASX ANNOUNCEMENT' and is clearly about board changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is about 5034 characters, which is sufficient for a detailed announcement but does not contain financial statements or other report content. Hence, the classification is MANG with high confidence.
2022-10-30 English
Initial Director's Interest Notice - D Hainsworth 2 pages 244.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the appointment of a director and the director's relevant interests in securities, including shareholdings and contracts. This type of document is a formal notification of personal share transactions or interests by a company director. It does not contain financial results, management discussion, or other report content. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on director interests, confirming this classification.
2022-10-30 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.